FindTrial
Sign In

To analyze the outcome and treatment strategy of isolated superior mesenteric artery dissection (ISMAD) based on anatomical morphology and hemodynamics

To analyze the outcome and treatment strategy of isolated superior mesenteric artery dissection (ISMAD) based on anatomical morphology and hemodynamics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400085531
Enrollment
Unknown
Registered
2024-06-11
Start date
2021-10-01
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Superior mesenteric artery dissection

Interventions

Patients with superior mesenteric artery dissection:None
Control:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with isolated superior mesenteric artery diagnosed by CTA

Exclusion criteria

Exclusion criteria: 1. Concomitant aortic dissection 2. History of major abdominal trauma 3. History of endovascular intervention of SMA 4. Superior mesenteric artery embolism or thrombosis 5. Intramural hematoma of the superior mesenteric artery

Design outcomes

Primary

MeasureTime frame
Tortuosity;Distortion;a angle;Diameter of the entrance of SMA;Diameter of the aorta 1 centimetre above the celiac artery;Diameter of the aorta at CA plane;—

Countries

China

Contacts

Public ContactDing Yuan

West China Hospital, Sichuan University

yuanding@wchscu.cn+86 189 8060 6344

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026